{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:48:45Z","timestamp":1753890525161,"version":"3.41.2"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>This study aims to evaluate the sensitivity and specificity of human T-lymphotropic virus type 1 (HTLV-1) antibody testing within hospitals located in HTLV-1 endemic areas of China.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>We performed a retrospective analysis of the clinical records and laboratory results for 1,147 patients who underwent HTLV-1 antibody testing using the Wantai HTLV-1 antibody detection kit and Polymerase Chain Reaction (PCR) testing for HTLV-1 nucleic acids, at Fujian Medical University Union Hospital between 2017 and 2023.<\/jats:p><\/jats:sec><jats:sec><jats:title>Result<\/jats:title><jats:p>The study population comprised 674 males (58.8%) and 473 females (41.2%), with an age distribution ranging from 7 to 86 years, and a median age of 50 years. Of the patients, 81 (7.1%) tested positive for HTLV-1 antibodies, including 39 males and 42 females. Predominantly, these positive cases were identified within the hematology department (93.8%). The cases originated from several high-prevalence coastal regions in Fujian province, such as Pingtan Island, Fuqing, Changle, Lianjiang, Fuan, Shouning, Xiapu, Zhouning, Fuding, Jiaocheng, Xiuyu, and Licheng. According to current standards for interpreting positive results, only 79.6% of patients with adult T-cell leukemia\/lymphoma (ATLL) confirmed by HTLV-1 nucleic acid testing presented positive antibody results. Comparison of HTLV-1 antibody and nucleic acid test results revealed that the antibody test possessed a sensitivity of 63.0% and a specificity of 94.8%. A receiver operating characteristic (ROC) curve analysis determined that a threshold of 0.335 signal-to-cutoff (S\/CO) was optimal for classifying positive antibody test results, yielding a sensitivity of 86.3% and a specificity of 94.4%.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The Wantai HTLV-1 antibody test kit, when utilized in hospitals within endemic regions, exhibits a high level of specificity. However, its sensitivity is found to be lacking when evaluated against the current standards for the interpretation of positive results. For patients with a high clinical suspicion of HTLV-1 infection-related diseases, it is crucial to conduct testing of HTLV-1 antibodies and nucleic acids.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2025.1474526","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T05:39:49Z","timestamp":1743658789000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Limitations of human t-lymphotropic virus type 1 antibody testing in hospitals of endemic regions in China"],"prefix":"10.3389","volume":"15","author":[{"given":"Yi","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianda","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengjun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1046\/j.1537-2995.1990.30991048781.x","article-title":"The prevalence of antibody to HTLV-I\/II in United States plasma donors and in United States and French hemophiliacs","volume":"30","author":"Canavaggio","year":"1990","journal-title":"Transfusion."},{"key":"B2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/978-981-10-5765-6_9","article-title":"Human T-cell leukemia virus type 1 infection and adult T-cell leukemia","volume":"1018","author":"Chan","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12977-020-00546-w","article-title":"Seroprevalence of human T-lymphotropic virus infection among blood donors in China: a first nationwide survey","volume":"18","author":"Chang","year":"2021","journal-title":"Retrovirology."},{"key":"B4","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1080\/17474086.2019.1632703","article-title":"Prevalence of human T-cell lymphotropic virus type-1 infection among blood donors in mainland China: a systematic review and meta-analysis of the last 20 years","volume":"12","author":"Chen","year":"2019","journal-title":"Expert Rev. Hematol."},{"key":"B5","first-page":"110","article-title":"Research on the morphology, immunology, cytogenetics, and clinical aspects of adult T-cell leukemia","volume":"8","author":"Chen","year":"1992","journal-title":"Chin. J. Hematology."},{"key":"B6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.virusres.2014.07.036","article-title":"History and update of HTLV infection in China","volume":"191","author":"Du","year":"2014","journal-title":"Virus Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1349-7006.1991.tb01856.x","article-title":"Improvement of gelatin particle agglutination test for detection of anti-HTLV-I antibody","volume":"82","author":"Fujino","year":"1991","journal-title":"Jpn J. Cancer Res."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2012.00388","article-title":"Epidemiological aspects and world distribution of HTLV-1 infection","volume":"3","author":"Gessain","year":"2012","journal-title":"Front. Microbiol."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1043600","article-title":"Geographic distribution, clinical epidemiology and genetic diversity of the human oncogenic retrovirus HTLV-1 in Africa, the world\u2019s largest endemic area","volume":"14","author":"Gessain","year":"2023","journal-title":"Front. Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/tme.12440","article-title":"Testing for HTLV 1 and HTLV 2 among blood donors in Western Saudi Arabia: prevalence and cost considerations","volume":"28","author":"Hindawi","year":"2018","journal-title":"Transfus Med."},{"key":"B11","first-page":"48","article-title":"Gene diagnosis of adult T-cell leukemia\/lymphoma","volume":"9","author":"Hu","year":"1996","journal-title":"Chin. J. Internal Med."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.00595","article-title":"A nationwide antenatal human T-cell leukemia virus type-1 antibody screening in Japan","volume":"11","author":"Itabashi","year":"2020","journal-title":"Front. Microbiol."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.01124","article-title":"Epidemiology of HTLV-1 infection and ATL in Japan: an update","volume":"11","author":"Iwanaga","year":"2020","journal-title":"Front. Microbiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12985-023-01970-y","article-title":"Development and validation of a duplex real-time PCR for the rapid detection and quantitation of HTLV-1","volume":"20","author":"Ji","year":"2023","journal-title":"Virol. J."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1128\/JCM.00169-17","article-title":"Evaluation of sensitivity and specificity performance of elecsys HTLV-I\/II assay in a multicenter study in europe and Japan","volume":"55","author":"Laperche","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.62347\/RARP1733","article-title":"Clinical characteristics, genetic alterations, and prognosis of adult T-cell leukemia\/lymphoma: an 11-year multicenter retrospective study in China","volume":"14","author":"Luo","year":"2024","journal-title":"Am. J. Cancer Res."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.00885","article-title":"Neuroimmunology of human T-lymphotropic virus type 1-associated myelopathy\/tropical spastic paraparesis","volume":"10","author":"Nozuma","year":"2019","journal-title":"Front. Microbiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1532\/IJH97.07070","article-title":"Allogeneic stem cell transplantation for adult T-cell leukemia\/lymphoma","volume":"86","author":"Okamura","year":"2007","journal-title":"Int. J. Hematol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"6058","DOI":"10.1038\/sj.onc.1208968","article-title":"Global epidemiology of HTLV-I infection and associated diseases","volume":"24","author":"Proietti","year":"2005","journal-title":"Oncogene."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1002\/jmv.24428","article-title":"Human T-Lymphotropic Virus Type 1 and 2 Seroprevalence among first-time blood donors in Chile, 2011-2013","volume":"88","author":"San Mart\u00edn","year":"2016","journal-title":"J. Med. Virol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e2200369","DOI":"10.1200\/GO.22.00369","article-title":"Epidemiological features and outcomes of HTLV-1 carriers diagnosed with cancer: A retrospective cohort study in an endemic country","volume":"9","author":"Valcarcel","year":"2023","journal-title":"JCO Glob Oncol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3390\/v11110974","article-title":"Influence of immunogenetic biomarkers in the clinical outcome of HTLV-1 infected persons","volume":"11","author":"Vallinoto","year":"2019","journal-title":"Viruses"},{"key":"B23","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/CCO.0000000000000883","article-title":"HTLV-1-related adult T-cell leukemia\/lymphoma: insights in early detection and management","volume":"34","author":"Wolf","year":"2022","journal-title":"Curr. Opin. Oncol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3760\/cma.j.issn.0253-2727.2016.12.003","article-title":"Clinical characteristics and prognosis in 12 patients with adult T cell leukemia\/lymphoma confirmed by HTLV-1 provirus gene detection","volume":"37","author":"Wu","year":"2016","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"B25","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1186\/s12879-020-05282-2","article-title":"HTLV screening of blood donors using chemiluminescence immunoassay in three major provincial blood centers of China","volume":"20","author":"Zhao","year":"2020","journal-title":"BMC Infect. Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e28424","DOI":"10.1002\/jmv.28424","article-title":"HTLV-1 persistent infection and ATLL oncogenesis","volume":"95","author":"Zuo","year":"2023","journal-title":"J. Med. Virol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1474526\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T05:40:08Z","timestamp":1743658808000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1474526\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":26,"alternative-id":["10.3389\/fcimb.2025.1474526"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2025.1474526","relation":{},"ISSN":["2235-2988"],"issn-type":[{"type":"electronic","value":"2235-2988"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"article-number":"1474526"}}